Search research articles
Contact Us
Filters
Showing results (61-70 of 112) with videos related to
Page
of 12
Sort By:
Neurology
|
December 31, 1997
Smoking and Parkinson's disease. An age-dependent risk effect? The EUROPARKINSON Study Group
C Tzourio, W A Rocca, M M Breteler, et al.
Magnetic Resonance in Medicine
|
July 10, 1999
1H chemical shift imaging of the human brain at age 60-90 years reveals metabolic differences between women and men
P E Sijens, M Oudkerk, F E de Leeuw, et al.
Stroke
|
July 2, 1999
Excess stroke among hypertensive men and women attributable to undertreatment of hypertension
O H Klungel, B H Stricker, A H Paes, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 11, 2001
Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly: the Rotterdam study
A E Hak, H A Pols, C D Stehouwer, et al.
Pharmacoeconomics
|
June 1, 2001
The cost of treatment of Alzheimer's disease in The Netherlands: a regression-based simulation model
J McDonnell, W K Redekop, N van der Roer, et al.
Neuroepidemiology
|
August 8, 2001
Prognosis of Alzheimer's disease: the Rotterdam Study
A Ruitenberg, S Kalmijn, M A de Ridder, et al.
Neurology
|
December 1, 1995
Prevalence of Parkinson's disease in the elderly: the Rotterdam Study
M C de Rijk, M M Breteler, G A Graveland, et al.
Lancet (London, England)
|
May 15, 1993
Cerebral white matter lesions and atherosclerosis in the Rotterdam Study
M L Bots, J C van Swieten, M M Breteler, et al.
Lancet (London, England)
|
July 4, 1998
Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study
A Ott, A J Slooter, A Hofman, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 13, 1998
A prospective study on cortisol, dehydroepiandrosterone sulfate, and cognitive function in the elderly
S Kalmijn, L J Launer, R P Stolk, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 112) with videos related to
Sort By:
Page
of 12
Neurology
|
December 31, 1997
Smoking and Parkinson's disease. An age-dependent risk effect? The EUROPARKINSON Study Group
C Tzourio, W A Rocca, M M Breteler, et al.
Magnetic Resonance in Medicine
|
July 10, 1999
1H chemical shift imaging of the human brain at age 60-90 years reveals metabolic differences between women and men
P E Sijens, M Oudkerk, F E de Leeuw, et al.
Stroke
|
July 2, 1999
Excess stroke among hypertensive men and women attributable to undertreatment of hypertension
O H Klungel, B H Stricker, A H Paes, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 11, 2001
Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly: the Rotterdam study
A E Hak, H A Pols, C D Stehouwer, et al.
Pharmacoeconomics
|
June 1, 2001
The cost of treatment of Alzheimer's disease in The Netherlands: a regression-based simulation model
J McDonnell, W K Redekop, N van der Roer, et al.
Neuroepidemiology
|
August 8, 2001
Prognosis of Alzheimer's disease: the Rotterdam Study
A Ruitenberg, S Kalmijn, M A de Ridder, et al.
Neurology
|
December 1, 1995
Prevalence of Parkinson's disease in the elderly: the Rotterdam Study
M C de Rijk, M M Breteler, G A Graveland, et al.
Lancet (London, England)
|
May 15, 1993
Cerebral white matter lesions and atherosclerosis in the Rotterdam Study
M L Bots, J C van Swieten, M M Breteler, et al.
Lancet (London, England)
|
July 4, 1998
Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study
A Ott, A J Slooter, A Hofman, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 13, 1998
A prospective study on cortisol, dehydroepiandrosterone sulfate, and cognitive function in the elderly
S Kalmijn, L J Launer, R P Stolk, et al.
Page
of 12